Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06128915 · ClinicalTrials.gov registry record · Phase 4

The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses

A Phase 4 study of Aging, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
Phase 4
Development phase
60
Enrollment target
1
Study location

NCT06128915 is a Phase 4 study of Aging that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 60 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06128915, a Phase 4 study of Aging, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
Phase 4
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.

Conditions Studied

Aging

Interventions

  • OTHER vaccine

Study Locations (1)

New York

  • University at Buffalo - Buffalo

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-01-08
Est. Completion 2026-05-31
Phase Phase 4

Sponsor

State University of New York at Buffalo

243 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06128915

The ClinicalTrials.gov registry entry for NCT06128915 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (97% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which vaccine is the first listed.

NCT06128915 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06128915 about?

NCT06128915 is a clinical study titled "The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses". This study focuses on the role of neutrophils in shaping the adaptive immune response to the anti-pneumococcal vaccine Prevnar-13 in young and elderly adults.

What is the current status of trial NCT06128915?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2024-01-08. Estimated completion is 2026-05-31.

What conditions does trial NCT06128915 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT06128915?

The interventions under investigation include: vaccine (OTHER).

Who is sponsoring clinical trial NCT06128915?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06128915 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aging

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.